diabetes

September 17, 2013

Researchers identify novel biomarker for diabetes risk

Researchers at the Vanderbilt Heart and Vascular Institute and Massachusetts General Hospital have identified a biomarker that can predict diabetes risk up to 10 years before onset of the disease.

By Kathy Whitney
September 12, 2013

VU tracking drug’s ability to prevent type 1 diabetes

Vanderbilt’s Eskind Diabetes Clinic has been selected to examine the ability of the drug abatacept to prevent type 1 diabetes (T1D). As part of the TrialNet consortium, Vanderbilt will be one of 14 North American sites observing the effects of the drug in people at high risk to develop T1D.

By VUMC News and Communications
August 22, 2013

Antipsychotic drug use in children for mood/behavior disorders increases type 2 diabetes risk

Prescribing “atypical” antipsychotic medications to children and young adults with behavioral problems or mood disorders may put them at unnecessary risk for type 2 diabetes, a Vanderbilt University Medical Center study shows.

By VUMC News and Communications
August 9, 2013

‘Yo-yo dieting’ inflames fat tissue

Gaining and losing weight during “yo-yo dieting” may contribute to an exaggerated immune response in fat tissue that increases metabolic dysfunction more than steady weight gain alone.

By Leigh MacMillan
August 8, 2013

Photo: Researching diabetes

Last week, 130 students from more than 75 medical schools across the nation were at Vanderbilt to take part in the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Medical Student Research Symposium, sponsored by the National Institutes of Health and organized by the Vanderbilt Diabetes Center.

By VUMC News and Communications
July 11, 2013

New service helps patients keep glucose levels on track

Following her successful heart valve surgery at Vanderbilt, Gwendolyn English and her family faced a long journey home to Florida. Her family was concerned about the trip, because English has diabetes and her blood sugar levels had been fluctuating erratically.

By VUMC News and Communications
June 6, 2013

Matrix member key to insulin resistance

A component of the extracellular matrix that surrounds cells plays a role in insulin resistance and may be a good therapeutic target.
By Leigh MacMillan
May 9, 2013

Russell’s diabetes treatment efforts honored

The Middle Tennessee Chapter of the Juvenile Diabetes Research Foundation (JDRF) has awarded Vanderbilt’s William Russell, M.D., professor of Pediatrics and director of the division of Pediatric Endocrinology and Diabetes, its highest honor — the Living and Giving Award for support of people diagnosed with type 1 diabetes (T1D).
By VUMC News and Communications
April 3, 2013

“Silent” B cells trigger autoimmunity

Immune cells that recognize self antigens (e.g. insulin), but are functionally silent, can trigger autoimmune diseases such as diabetes.
By Leigh MacMillan
February 28, 2013

Discovery Lecture explores brain’s sensitivity to insulin

Diabetes has a big impact on the brain.
By Bill Snyder
February 18, 2013

Pancreas cells full of potential

Adult cells in the pancreas can return to a less mature state – and then become a different cell type, like the beta cells that secrete insulin.
By Jessica Mazerik
February 14, 2013

Harvard’s Kahn set for Discovery Lecture

C. Ronald Kahn, M.D., renowned for his contributions to the field of insulin signaling and its role in type 2 diabetes and obesity, will deliver the next Flexner Discovery Lecture on Thursday, Feb. 21.
By Bill Snyder
November 29, 2012

ADA, Vanderbilt united in fight against diabetes

The statistics are jarring. More than 25.8 million children and adults in the United States — 8.3 percent of the population — have diabetes. And predictions are that one in three people will have the chronic disease by 2050.
By Nancy Humphrey
1 … 13 14 15 16 17 18